Editorial: Ketamine for treatment of acute and chronic pain: The relationship of mechanism and exposure to therapeutic outcome.
作者信息
Dahan Albert, Henthorn Thomas K
机构信息
Department of Anesthesiology, Leiden University Medical Center, Leiden, Netherlands.
PainLess Foundation, Leiden, Netherlands.
出版信息
Front Pain Res (Lausanne). 2022 Aug 23;3:991569. doi: 10.3389/fpain.2022.991569. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Ketamine for treatment of acute and chronic pain: The relationship of mechanism and exposure to therapeutic outcome.社论：氯胺酮用于治疗急慢性疼痛：作用机制及用药量与治疗效果的关系
Front Pain Res (Lausanne). 2022 Aug 23;3:991569. doi: 10.3389/fpain.2022.991569. eCollection 2022.
2
Subanesthetic, Subcutaneous Ketamine Infusion Therapy in the Treatment of Chronic Nonmalignant Pain.亚麻醉剂量皮下注射氯胺酮输注疗法治疗慢性非恶性疼痛
J Pain Palliat Care Pharmacother. 2016 Jun;30(2):91-8. doi: 10.3109/15360288.2016.1161690. Epub 2016 Apr 19.
3
Development of a sublingual/oral formulation of ketamine for use in neuropathic pain: Preliminary findings from a three-way randomized, crossover study.用于神经性疼痛的氯胺酮舌下/口服制剂的研发：一项三向随机交叉研究的初步结果。
Clin Drug Investig. 2009;29(5):317-24. doi: 10.2165/00044011-200929050-00004.
4
Efficacy and Tolerability of Oral Compared with Sublingual Ketamine Lozenges as Rescue Analgesics in Adults for Acute Pain: The OSKet Trial.口腔与舌下含服氯胺酮含片作为成人急性疼痛解救镇痛剂的疗效和耐受性：OSKet 试验。
Clin Drug Investig. 2021 Sep;41(9):817-823. doi: 10.1007/s40261-021-01066-x. Epub 2021 Aug 8.
5
Targeting Affective Mood Disorders With Ketamine to Prevent Chronic Postsurgical Pain.以氯胺酮治疗情感性心境障碍预防慢性术后疼痛
Front Pain Res (Lausanne). 2022 Jun 27;3:872696. doi: 10.3389/fpain.2022.872696. eCollection 2022.
6
Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression.经鼻内给予极低剂量氯胺酮治疗难治性单相和双相抑郁的抗抑郁、稳定情绪和认知增强作用。
Int J Neuropsychopharmacol. 2013 Oct;16(9):2111-7. doi: 10.1017/S1461145713000485. Epub 2013 May 20.
7
A review of the use of ketamine in pain management.氯胺酮在疼痛管理中的应用综述。
J Opioid Manag. 2013 Sep-Oct;9(5):379-88. doi: 10.5055/jom.2013.0180.
8
A systematic review of therapeutic ketamine use in children and adolescents with treatment-resistant mood disorders.治疗抵抗性心境障碍儿童和青少年中治疗用氯胺酮的系统评价。
Eur Child Adolesc Psychiatry. 2021 Oct;30(10):1485-1501. doi: 10.1007/s00787-020-01542-3. Epub 2020 May 8.
9
The place of S-ketamine in fibromyalgia treatment (ESKEFIB): study protocol for a prospective, single-center, double-blind, randomized, parallel-group, dose-escalation controlled trial.S-氯胺酮治疗纤维肌痛症（ESKEFIB）的研究方案：一项前瞻性、单中心、双盲、随机、平行分组、剂量递增对照试验。
Trials. 2021 Nov 27;22(1):853. doi: 10.1186/s13063-021-05814-4.
10
Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: a longitudinal study.亚麻醉剂量氯胺酮输注治疗儿童和青少年慢性疼痛的纵向研究。
BMC Pediatr. 2015 Dec 1;15:198. doi: 10.1186/s12887-015-0515-4.
引用本文的文献
1
Elevated circulating soluble interleukin-2 receptor (sCD25) level is associated with prefrontal excitatory-inhibitory imbalance in individuals with chronic pain: A proton MRS study.循环中可溶性白细胞介素-2 受体（sCD25）水平升高与慢性疼痛患者前额叶兴奋-抑制失衡有关：一项质子磁共振波谱研究。
Brain Behav Immun. 2024 Aug;120:1-9. doi: 10.1016/j.bbi.2024.05.020. Epub 2024 May 19.
本文引用的文献
1
Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search.（2R,6R）-羟基去甲凯他明的靶向去卷积研究：一场难以捉摸的探索。
Mol Psychiatry. 2022 Oct;27(10):4144-4156. doi: 10.1038/s41380-022-01673-w. Epub 2022 Jun 29.
2
Association between prescription opioid use and unplanned intensive care unit admission and mortality in the adult population of the Netherlands: a registry study.荷兰成年人人群中处方阿片类药物使用与非计划性重症监护病房入院和死亡的相关性：一项注册研究。
Br J Anaesth. 2022 Aug;129(2):254-262. doi: 10.1016/j.bja.2022.05.009. Epub 2022 Jun 22.
3
Reducing opioid use disorder and overdose deaths in the United States: A dynamic modeling analysis.减少美国阿片类药物使用障碍和过量死亡人数：一项动态建模分析。
Sci Adv. 2022 Jun 24;8(25):eabm8147. doi: 10.1126/sciadv.abm8147.
4
Ketamine Analgesia and Psychedelia: Can We Dissociate Dissociation?氯胺酮镇痛与致幻作用：我们能否分离解离现象？
Anesthesiology. 2022 May 1;136(5):675-677. doi: 10.1097/ALN.0000000000004172.
5
Ketamine Psychedelic and Antinociceptive Effects Are Connected.氯胺酮的致幻作用和镇痛作用相互关联。
Anesthesiology. 2022 May 1;136(5):792-801. doi: 10.1097/ALN.0000000000004176.
6
Transient Stimulation with Psychoplastogens Is Sufficient to Initiate Neuronal Growth.使用精神塑造剂进行短暂刺激足以启动神经元生长。
ACS Pharmacol Transl Sci. 2020 Sep 11;4(2):452-460. doi: 10.1021/acsptsci.0c00065. eCollection 2021 Apr 9.
7
Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms.氯胺酮使用 50 年：从麻醉到快速抗抑郁作用和神经生物学机制。
Pharmacol Rep. 2021 Apr;73(2):323-345. doi: 10.1007/s43440-021-00232-4. Epub 2021 Feb 20.
8
Ketamine does not produce relief of neuropathic pain in mice lacking the β-common receptor (CD131).氯胺酮在缺乏β-共用受体（CD131）的小鼠中不能缓解神经病理性疼痛。
PLoS One. 2013 Aug 1;8(8):e71326. doi: 10.1371/journal.pone.0071326. Print 2013.
9
Synaptic dysfunction in depression: potential therapeutic targets.抑郁症中的突触功能障碍：潜在的治疗靶点。
Science. 2012 Oct 5;338(6103):68-72. doi: 10.1126/science.1222939.
10
The involvement of the mu-opioid receptor in ketamine-induced respiratory depression and antinociception.μ-阿片受体在氯胺酮诱导的呼吸抑制和抗伤害感受中的作用。
Anesth Analg. 2001 Dec;93(6):1495-500, table of contents. doi: 10.1097/00000539-200112000-00031.
Zotero 插件